Found: 13
Select item for more details and to access through your institution.
Generic development and market exclusivity period in China: an analysis from 2003 to 2020.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2024, v. 33, n. 1, p. 57, doi. 10.5246/jcps.2024.01.006
- By:
- Publication type:
- Article
Health status of middle-aged and elderly cancer survivors in China.
- Published in:
- Journal of Chinese Pharmaceutical Sciences, 2023, v. 32, n. 9, p. 744, doi. 10.5246/jcps.2023.09.061
- By:
- Publication type:
- Article
Effects of the Full Coverage Policy of Essential Medicines on Inequality in Medication Adherence: A Longitudinal Study in Taizhou, China.
- Published in:
- Frontiers in Pharmacology, 2022, v. 13, p. 1, doi. 10.3389/fphar.2022.802219
- By:
- Publication type:
- Article
Use of suboptimal control arms in randomized clinical trials of investigational cancer drugs in China, 2016–2021: An observational study.
- Published in:
- PLoS Medicine, 2023, v. 20, n. 12, p. 1, doi. 10.1371/journal.pmed.1004319
- By:
- Publication type:
- Article
Cost-effectiveness of durvalumab plus tremelimumab in combination with chemotherapy for the treatment of metastatic non-small-cell lung cancer from the US healthcare sector's and societal perspectives.
- Published in:
- Frontiers in Pharmacology, 2024, p. 1, doi. 10.3389/fphar.2024.1256992
- By:
- Publication type:
- Article
Effectiveness of hierarchical medical system policy: an interrupted time series analysis of a pilot scheme in China.
- Published in:
- Health Policy & Planning, 2023, v. 38, n. 5, p. 609, doi. 10.1093/heapol/czad018
- By:
- Publication type:
- Article
Benzodiazepine Receptor Agonists Prescribing for Insomnia Among Adults in Primary Health Care Facilities in Beijing, China.
- Published in:
- JAMA Network Open, 2023, v. 6, n. 2, p. e230044, doi. 10.1001/jamanetworkopen.2023.0044
- By:
- Publication type:
- Article
Prices and Clinical Benefit of National Price-Negotiated Anticancer Medicines in China.
- Published in:
- PharmacoEconomics, 2022, v. 40, n. 7, p. 715, doi. 10.1007/s40273-022-01161-7
- By:
- Publication type:
- Article
The impact of government reimbursement negotiation on targeted anticancer medicines use and cost in China: A cohort study based on national health insurance data.
- Published in:
- Journal of Global Health, 2023, v. 13, p. 1, doi. 10.7189/jogh.13.04083
- By:
- Publication type:
- Article
Disparity in Guideline‐Based Antidiabetic Drugs Prescribing for Type 2 Diabetes Patients in Primary Healthcare Facilities Across China, 2017–2019.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2024, v. 33, n. 8, p. 1, doi. 10.1002/pds.5882
- By:
- Publication type:
- Article
Evaluation of prescription review and feedback policy on rational antibiotic use in primary healthcare settings in Beijing, China: a qualitative study using the Theoretical Domains Framework and the behaviour change wheel.
- Published in:
- JAC-Antimicrobial Resistance, 2023, v. 5, n. 6, p. 1, doi. 10.1093/jacamr/dlad128
- By:
- Publication type:
- Article
"[T]he laws need to change to reflect current society": Insights from stakeholders involved in development, review or implementation of policies about adolescent consent for HIV testing, care and research in Kenya.
- Published in:
- Journal of the International AIDS Society, 2023, v. 26, n. 1, p. 1, doi. 10.1002/jia2.26057
- By:
- Publication type:
- Article
Potentially inappropriate medications among older patients with Parkinson's disease: a cross-sectional analysis of a national health insurance database in China.
- Published in:
- BMC Geriatrics, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12877-023-04547-0
- By:
- Publication type:
- Article